Advancing cell & gene therapy - optimizing lentiviral vector design and production | Johnson & Johnson | Leiden (NL) & Online

What: Advancing cell & gene therapy - optimizing lentiviral vector design and production

When: November 27, 2024 | 2 to 6 pm

Where: Leiden Bio Science Park (NL) & Online

Info: In this symposium, we will address key questions facing the biotech industry today: What are some of the main challenges in improving cutting-edge manufacturing techniques? How can we boost LVV yield and enhance safety profiles? What insights can we gain from viral vector production applied in other areas like vaccines and gene therapy?

Join us during this Johnson & Johnson Innovation – JLABS program as we delve into the latest advancements in viral vector production, focusing specifically on lentiviral vectors. We will also explore potential future developments and identify bottlenecks that may hinder implementation. Through collaboration and ongoing research, we aim to overcome these challenges and unlock the full potential of cell therapies, paving the way for innovative treatments that improve patient outcomes and benefit healthcare systems worldwide.

Registration:Link